Altogether, our findings suggest that reduced IL-6 levels during HT may contribute to enhanced naive CD8+ T-cell hematopoiesis and a decrease in the proportions of exhausted CTLA4-expressing CD8+ T cells following HT (Supplementary Figure 5). The gene discussed is CTLA4; the disease is hematocrit.